Human Coagulation Factor X Alexa Fluor® 405-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # AF1063V
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Leu24-Lys488
Accession # P00742
Specificity
Clonality
Host
Isotype
Applications
Immunoprecipitation
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Shipping
Stability & Storage
Background: Coagulation Factor X
Factor X (Coagulation factor X; also Stuart factor) is a 74-76 kDa glycoprotein member of the peptidase S1 family of molecules. It is secreted by hepatocytes, and plays a key role in the coagulation cascade. Normally, Factor X circulates as a zymogen (or inactive form). Upon disruption of the vasculature, Factor X, and the circulating zymogen Factor V interact, and form what's called the prothrombinase complex on negatively-charged membrane phospholipids of platelets and endothelial cells. This complex converts prothrombin (Factor II) into thrombin, and thus initiates clot formation. Factor X (as a zymogen) is a disulfide-linked heterodimer. Its two chains are the result of intracellular processing of a 74-76 kDa single chain precursor. This creates a 55-57 kDa C-terminal heavy chain, and a 17-18 kDa N-terminal light chain. Prothrombinase complex formation results in the cleavage of the heavy chain, leading to the generation of a 45-46 kDa, prothrombin-cleaving active chain, and a soluble 10 kDa activation fragment. Cleavage is not the result of Factor V activity, but that of either Tissue Factor or Factor IXa, and the activities of there two enzymes are tightly regulated by the carbohydrates bound to the 10 kDa activation fragment. Mature human Factor X is synthesized as a 488 amino acid (aa) preproprecursor that contains a 31 aa signal sequence, a 9 aa prosegment (aa 32-40), a 139 aa light chain (aa 41-179), and a 306 aa heavy chain (aa 183-488). The light chain possesses a Gla domain that binds to Factor V (aa 41-85) plus two EGF-like motifs (aa 86-165), while the heavy chain contains the activation peptide sequence (aa 183-234) followed by a large peptidase S1 domain (aa 235-467). Over aa 24-488, human Factor X shares 77% aa sequence identity with mouse Factor X.
Alternate Names
Gene Symbol
UniProt
Additional Coagulation Factor X Products
Product Specific Notices
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
For research use only